Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Urinary Retention Therapeutics Market

Urinary Retention Therapeutics Market Share

Report ID: GMI5771
Published Date: May 2023
Report Format: PDF

Download Free Sample

Urinary Retention Therapeutics Market Share

Some of the major market players operating in the urinary retention therapeutics market are

Merck KGaA
Sanofi
Pfizer Inc
GlaxoSmithKline plc.
Eli Lilly
Astellas Pharma Inc.
Bayer AG
Johnson & Johnson
Novartis AG
Sun Pharmaceutical Industries Ltd.

These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for urinary retention therapeutic will record a 5.8% CAGR between 2023 to 2032.

Stress incontinence segment was 36.4% in 2022 due to high prevalence and negative impact of stress incontinence.

North America urinary retention therapeutic market surpassed of USD 889.2 million in 2022, owing to a high prevalence of urinary retention conditions in the region.

Merck KGaA, Sanofi, Pfizer Inc., GlaxoSmithKline plc., Eli Lilly, Astellas Pharma Inc., Bayer AG, Johnson & Johnson, Novartis AG, and Sun Pharmaceutical Industries Ltd.